Taiwan · Delayed Price · Currency is TWD AnnJi Pharmaceutical Statistics
Total Valuation
TPEX:7754 has a market cap or net worth of TWD 4.33 billion. The enterprise value is 3.88 billion.
| Market Cap | 4.33B |
| Enterprise Value | 3.88B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:7754 has 93.88 million shares outstanding. The number of shares has increased by 3.49% in one year.
| Current Share Class | 93.88M |
| Shares Outstanding | 93.88M |
| Shares Change (YoY) | +3.49% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 1.83% |
| Owned by Institutions (%) | 12.48% |
| Float | 57.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 181.65 |
| PB Ratio | 8.49 |
| P/TBV Ratio | 10.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.23 |
| EV / Sales | 162.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -13.19 |
Financial Position
The company has a current ratio of 4.99, with a Debt / Equity ratio of 0.10.
| Current Ratio | 4.99 |
| Quick Ratio | 4.67 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.18 |
| Interest Coverage | -201.18 |
Financial Efficiency
Return on equity (ROE) is -48.06% and return on invested capital (ROIC) is -29.73%.
| Return on Equity (ROE) | -48.06% |
| Return on Assets (ROA) | -22.26% |
| Return on Invested Capital (ROIC) | -29.73% |
| Return on Capital Employed (ROCE) | -50.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.80 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.55% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +30.55% |
| 50-Day Moving Average | 46.78 |
| 200-Day Moving Average | 32.12 |
| Relative Strength Index (RSI) | 46.20 |
| Average Volume (20 Days) | 244,840 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:7754 had revenue of TWD 23.85 million and -317.13 million in losses. Loss per share was -3.38.
| Revenue | 23.85M |
| Gross Profit | 468,000 |
| Operating Income | -340.19M |
| Pretax Income | -317.13M |
| Net Income | -317.13M |
| EBITDA | -302.46M |
| EBIT | -340.19M |
| Loss Per Share | -3.38 |
Balance Sheet
The company has 505.55 million in cash and 52.37 million in debt, giving a net cash position of 453.18 million or 4.83 per share.
| Cash & Cash Equivalents | 505.55M |
| Total Debt | 52.37M |
| Net Cash | 453.18M |
| Net Cash Per Share | 4.83 |
| Equity (Book Value) | 510.25M |
| Book Value Per Share | 5.44 |
| Working Capital | 434.18M |
Cash Flow
In the last 12 months, operating cash flow was -291.89 million and capital expenditures -2.23 million, giving a free cash flow of -294.12 million.
| Operating Cash Flow | -291.89M |
| Capital Expenditures | -2.23M |
| Free Cash Flow | -294.12M |
| FCF Per Share | -3.13 |
Margins
| Gross Margin | 1.96% |
| Operating Margin | -1,426.25% |
| Pretax Margin | -1,329.58% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:7754 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.49% |
| Shareholder Yield | -3.49% |
| Earnings Yield | -7.32% |
| FCF Yield | -6.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:7754 has an Altman Z-Score of 3.05 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.05 |
| Piotroski F-Score | 2 |